Page 216 - Grow from Within Mastering Corporate Entrepreneurship and Innovation
P. 216

Leadership from All Le vels     201


            A Producer Produces at Baxter International


              Smart companies actively develop potential corporate entre-
              preneurs, or at least offer those within the organization who
              have company-building experience the opportunity to further
              refine and leverage those capabilities. Most companies should
              have dedicated new business creation programs and/or teams,
              but even companies without such entities typically have some
              personnel who possess these skills and interests. These people
              can be either enabled to create growth opportunities on a case-
              by-case basis or included as part of a larger corporate entre-
              preneurship initiative.
                 The story of Andrea Hunt and her Non-Traditional Research
              and Innovation (NTRI, pronounced “entry”) team at Baxter
              International illustrates how corporate entrepreneurs emerge,
              develop, and ultimately affect a company’s bottom line. Hunt
              joined Chicago area–based medical products company Baxter
              International in 1988 and rose through the ranks, leading com-
              panywide change programs such as TQM and Customer Satis-
              faction. The breadth of the trusted relationships she built across
              the company during these successful initiatives prepared her for
              her eventual role as vice president of NTRI. Founded in 2000,
              NTRI was charged by the CEO, Harry Kraemer, with identify-
              ing, validating, and building entirely new businesses for Baxter
              that were consistent with the company’s long-term vision but
              were not opportunities that would typically be pursued by busi-
              ness units. Concurrently, Baxter initiated an innovation leader-
              ship team (ILT) made up of six top functional executives and the
              presidents of each of the business units to oversee the growth
              portfolio.
                 In 2002, Kraemer named senior Baxter R&D executive Nor-
              bert Riedel as corporate chief scientific officer (CSO). When
              Riedel first joined Baxter in 1998, he was surprised at the com-
   211   212   213   214   215   216   217   218   219   220   221